 
                        | Product NDC: | 0409-2306 | 
| Proprietary Name: | MIDAZOLAM Hydrochloride | 
| Non Proprietary Name: | MIDAZOLAM HYDROCHLORIDE | 
| Active Ingredient(s): | 1 mg/mL & nbsp; MIDAZOLAM HYDROCHLORIDE | 
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0409-2306 | 
| Labeler Name: | Hospira, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075856 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20020613 | 
| Package NDC: | 0409-2306-12 | 
| Package Description: | 10 SYRINGE in 1 CARTON (0409-2306-12) > 2 mL in 1 SYRINGE | 
| NDC Code | 0409-2306-12 | 
| Proprietary Name | MIDAZOLAM Hydrochloride | 
| Package Description | 10 SYRINGE in 1 CARTON (0409-2306-12) > 2 mL in 1 SYRINGE | 
| Product NDC | 0409-2306 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | MIDAZOLAM HYDROCHLORIDE | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAMUSCULAR; INTRAVENOUS | 
| Start Marketing Date | 20020613 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Hospira, Inc. | 
| Substance Name | MIDAZOLAM HYDROCHLORIDE | 
| Strength Number | 1 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |